Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib
Sponsor: Asociatia Oncohelp - Centrul de Oncologie Oncohelp
Collaborators: MDX Research